273
Participants
Start Date
December 31, 2008
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
AC2307
subcutaneous, twice daily, low dose
placebo
subcutaneous, twice daily, low dose
AC2307
subcutaneous, twice daily, middle dose
placebo
subcutaneous, twice daily, middle dose
AC2307
subcutaneous, twice daily, high dose
placebo
subcutaneous, twice daily, high dose
Research Site, Birmingham
Research Site, Chandler
Research Site, Santa Rosa
Research Site, Walnut Creek
Research Site, Denver
Research Site, Jacksonville
Research Site, Miami
Research Site, Chicago
Research Site, Overland Park
Research Site, Baton Rouge
Research Site, Butte
Research Site, Cincinnati
Research Site, Eugene
Research Site, Medford
Research Site, Greer
Research Site, Mt. Pleasant
Research Site, Austin
Research Site, Olympia
Lead Sponsor
AstraZeneca
INDUSTRY